Proteomic analysis of 14-3-3 zeta binding proteins in the mouse hippocampus

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 4, Issue 2, 2012, Pages 74-83

  Heverin, Maura ^a   Brennan, Gary P ^a   Koehler, Christian J ^a   Treumann, Achim ^a   Henshall, David C ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

14 3 3 interactome; Apoptosis; Epilepsy; Hippocampus; Mass spectrometry; Proteomics

Indexed keywords

LAMIN A; LAMIN C; PORIN; PROTEIN 14 3 3; PROTEIN BCL 2;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; ENDOPLASMIC RETICULUM; EXCITOTOXICITY; GOLGI COMPLEX; HIPPOCAMPUS; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; PROTEOMICS; SYNAPTIC TRANSMISSION;

EID: 84863933656     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Fu H, Subramanian RR and Masters SC. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000; 40: 617-647.
2. Tzivion G, Shen YH and Zhu J. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 2001; 20: 6331-6338.
3. Aitken A. 14-3-3 proteins: a historic overview. Semin Cancer Biol 2006; 16: 162-172.
4. Kleppe R, Martinez A, Doskeland SO and Haavik J. The 14-3-3 proteins in regulation of cellular metabolism. Semin Cell Dev Biol 2011; 22: 713-719.
5. Berg D, Holzmann C and Riess O. 14-3-3 proteins in the nervous system. Nat Rev Neurosci 2003; 4: 752-762.
6. Martin H, Rostas J, Patel Y and Aitken A. Subcellular localization of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 1994; 63: 2259-2265.
7. Schindler CK, Heverin M and Henshall DC. Isoform-and subcellular fraction-specific differences in hippocampal 14-3-3 levels following experimentally evoked seizures and in human temporal lobe epilepsy. J Neurochem 2006; 99: 561-569.
8. Wang J, Lou HY, Pedersen CJ, Smith AD and Perez RG. 14-3-3 zeta contributes to tyrosine hydroxylase activity in MN9D cells: Localization of dopamine regulatory protein sto mitochondria. J Biol Chem 2009; 284: 14011-14019.
9. Bridges D and Moorhead GB. 14-3-3 proteins: a number of functions for a numbered protein. Sci STKE 2005; 2005: re10.
10. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ and Cantley LC. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 1997; 91: 961-971.
11. Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N and Mackintosh C. 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J 2004; 379: 395-408.
12. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, Metalnikov P, O'Donnell P, Taylor P, Taylor L, Zougman A, Woodgett JR, Langeberg LK, Scott JD and Pawson T. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 2004; 14: 1436-1450.
13. Benzinger A, Muster N, Koch HB, Yates JR and Hermeking H. Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol Cell Proteomics 2005; 4: 785-795.
14. Chang IF, Curran A, Woolsey R, Quilici D, Cushman JC, Mittler R, Harmon A and Harper JF. Proteomic profiling of tandem affinity purified 14-3-3 protein complexes in Arabidopsis thaliana. Proteomics 2009; 9: 2967-2985.
15. Satoh J, Nanri Y and Yamamura T. Rapid identification of 14-3-3-binding proteins by protein microarray analysis. J Neurosci Meth 2006; 152: 278-288.
16. Freeman AK and Morrison DK. 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression. Semin Cell Dev Biol 2011; 22: 681-687.
17. Hashiguchi M, Sobue K and Paudel HK. 14-3-3 zeta is an effector of tau protein phosphorylation. J Biol Chem 2000; 275: 25247-25254.
18. Umahara T, Uchihara T, Yagishita S, Nakamura A, Tsuchiya K and Iwamoto T. Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1. Neurosci Lett 2007; 414: 130-135.
19. Cheah PS, Ramshaw HS, Thomas PQ, Toyo-Oka K, Xu X, Martin S, Coyle P, Guthridge MA, Stomski F, van den Buuse M, Wynshaw-Boris A, Lopez AF and Schwarz QP. Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3 zeta deficiency. Molecular Psychiatry 2012; 17: 451-466.
20. Murphy N, Bonner HP, Ward MW, Murphy BM, Prehn JHM and Henshall DC. Depletion of 14-3-3 zeta elicits endoplasmic reticulum stress and cell death, and increases vulnerability to kainate-induced injury in mouse hippocampal cultures. J Neurochem 2008; 106: 978-988.
21. Kim YS, Choi MY, Kim YH, Jeon BT, Lee DH, Roh GS, Kang SS, Kim HJ, Cho GJ and Choi WS. Protein kinase Cdelta is associated with 14-3-3 phosphorylation in seizure-induced neuronal death. Epilepsy Res 2010; 92: 30-40.
22. Murphy N, Yamamoto A and Henshall DC. Detection of 14-3-3 zeta in cerebrospinal fluid following experimentally evoked seizures. Biomarkers 2008; 13: 377-384.
23. Schoonheim PJ, Veiga H, Pereira DD, Friso G, van Wijk KJ and de Boer AH. A comprehensive analysis of the 14-3-3 interactome in barley leaves using a complementary proteomics and two-hybrid approach. Plant Physiology 2007; 143: 670-683.
24. Kijanka G, Ipcho S, Baars S, Chen H, Hadley K, Beveridge A, Gould E and Murphy D. Rapid characterization of binding specificity and cross-reactivity of antibodies using recombinant human protein arrays. J Immunol Methods 2009; 340: 132-137.
25. Craig R and Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004; 20: 1466-1467.
26. Gupta N, Bandeira N, Keich U and Pevzner PA. Target-decoy approach and false discovery rate: when things may go wrong. J Am Soc Mass Spectrom 2011; 22: 1111-1120.
27. Schindler CK, Shinoda S, Simon RP and Henshall DC. Subcellular distribution of Bcl-2 family proteins and 14-3-3 within the hippocampus during seizure-induced neuronal death in the rat. Neurosci Lett 2004; 356: 163-166.
28. McKiernan RC, Jimenez-Mateos EM, Bray I, Engel T, Brennan GP, Sano T, Michalak Z, Moran C, Delanty N, Farrell M, O'Brien D, Meller R, Simon RP, Stallings RL and Henshall DC. Reduced mature microRNA levels in association with Dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS One 2012; 7: e35921.
29. Meek SE, Lane WS and Piwnica-Worms H. Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. J Biol Chem 2004; 279: 32046-32054.
30. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 2012; 13: 89-102.
31. Ichimura T, Wakamiya-Tsuruta A, Itagaki C, Taoka M, Hayano T, Natsume T and Isobe T. Phosphorylation-dependent interaction of kinesin light chain 2 and the 14-3-3 protein. Biochemistry 2002; 41: 5566-5572.
32. Godde NJ, D'Abaco GM, Paradiso L and Novak U. Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members. J Cell Sci 2006; 119: 3296-3305.
33. Birkenfeld J, Betz H and Roth D. Identification of cofilin and LIM-domain-containing protein kinase 1 as novel interaction partners of 14-3-3 zeta. Biochem J 2003; 369: 45-54.
34. Dorner C, Ullrich A, Haring HU and Lammers R. The kinesin-like motor protein KIF1C occurs in intact cells as a dimer and associates with proteins of the 14-3-3 family. J Biol Chem 1999; 274: 33654-33660.
35. Hanson PI, Otto H, Barton N and Jahn R. The Nethylmaleimide-sensitive fusion protein and alpha-SNAP induce a conformational change in syntaxin. J Biol Chem 1995; 270: 16955-16961.
36. Mizuno E, Kitamura N and Komada M. 14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. Exp Cell Res 2007; 313: 3624-3634.
37. Choi HH, Gully C, Su CH, Velazquez-Torres G, Chou PC, Tseng C, Zhao R, Phan L, Shaiken T, Chen J, Yeung SC and Lee MH. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3sigma. Oncogene 2011; 30: 4791-4801.
38. Urano T, Saito T, Tsukui T, Fujita M, Hosoi T, Muramatsu M, Ouchi Y and Inoue S. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 2002; 417: 871-875.
39. Diviani D, Abuin L, Cotecchia S and Pansier L. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. EMBO J 2004; 23: 2811-2820.
40. Lee S, Lee K, Hwang S, Kim SH, Song WK, Park ZY and Chang S. SPIN90/WISH interacts with PSD-95 and regulates dendritic spinogenesis via an N-WASP-independent mechanism. EMBO J 2006; 25: 4983-4995.
41. Alcala S, Klee M, Fernandez J, Fleischer A and Pimentel-Muinos FX. A high-throughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release. Oncogene 2008; 27: 44-54.
42. Gu W, Brodtkorb E and Steinlein OK. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol 2002; 52: 364-367.
43. Wibom R, Lasorsa FM, Tohonen V, Barbaro M, Sterky FH, Kucinski T, Naess K, Jonsson M, Pierri CL, Palmieri F and Wedell A. AGC1 deficiency associated with global cerebral hypomyelination. N Engl J Med 2009; 361: 489-495.
44. Park KD, Kim D, Reamtong O, Eyers C, Gaskell SJ, Liu R and Kohn H. Identification of a lacosamide binding protein using an affinity bait and chemical reporter strategy: 14-3-3 zeta. J Am Chem Soc 2011; 133: 11320-11330.
45. Shikano S, Coblitz B, Wu M and Li M. 14-3-3 proteins: regulation of endoplasmic reticulum localization and surface expression of membrane proteins. Trends Cell Biol 2006; 16: 370-375.
46. Tzivion G, Luo Z and Avruch J. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 1998; 394: 88-92.
47. Dai JG and Murakami K. Constitutively and autonomously active protein kinase C associated with 14-3-3 zeta in the rodent brain. J Neurochem 2003; 84: 23-34.
48. Toyo-oka K, Shionoya A, Gambello MJ, Cardoso C, Leventer R, Ward HL, Ayala R, Tsai LH, Dobyns W, Ledbetter D, Hirotsune S and Wynshaw-Boris A. 14-3-3 epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Gen 2003; 34: 274-285.
49. Tenney JR, Hopkin RJ and Schapiro MB. Deletion of 14-3-3 epsilon and CRK: A Clinical Syndrome With Macrocephaly, Developmental Delay, and Generalized Epilepsy. J Child Neurol 2011; 26: 223-227.
50. Grozinger CM and Schreiber SL. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci USA 2000; 97: 7835-7840.
51. Rajendran P, Delage B, Dashwood WM, Yu TW, Wuth B, Williams DE, Ho E and Dashwood RH. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/ SMRT corepressor complex dissociation/ reassembly. Mol Cancer 2011; 10: 68.